The data came from a phase 3 trial that enrolled 29,960 participants across 119 sites in the U.S. and Mexico. Novavax said it recruited participants from the communities and demographic groups most affected by COVID-19.
Should the vaccine be cleared by the FDA, Novavax is ready to manufacture 150 million doses each month by the end of 2021.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
